Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026

Go back to Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
SmartPros Ltd. (NASDAQ: SPRO) Delayed: 2.21 --0 (-0%)
Previous Close $2.21    52 Week High $3.85 
Open $2.21    52 Week Low $1.25 
Day High $2.21    P/E N/A 
Day Low $2.21    EPS $-0.28 
Volume 36,726